Society guideline links: Antiphospholipid syndrome

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International Society on Thrombosis and Haemostasis (ISTH): Guidance for lupus anticoagulant detection in anticoagulated patients (2020)

●ISTH: Guidance for lupus anticoagulant/antiphospholipid antibodies (2020)

●ISTH: Guidance for the use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome (2020)

●ISTH: Guidance on testing for antiphospholipid antibodies with solid phase assays (2014)

Canada

●Thrombosis Canada: Clinical guide on thrombophilia – Antiphospholipid antibody syndrome (2022)

United States

●American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR): Antiphospholipid syndrome classification criteria (2023)

●American College of Chest Physicians (CHEST): Guideline and expert panel report on antithrombotic therapy for VTE disease, second update (2021)

●ACR: Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases (2020)

●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on antiphospholipid syndrome (2012)

Europe

●American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR): Antiphospholipid syndrome classification criteria (2023)

●EULAR: Recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome (2022)

●EULAR: Recommendations for the management of antiphospholipid syndrome in adults (2019)

●EULAR: Recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases, update (2019)

●EULAR: Recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome (2017)

●Single Hub and Access point for paediatric Rheumatology in Europe (SHARE): European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome (2017)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on venous thromboembolic diseases – Diagnosis, management, and thrombophilia testing (2020, updated 2023)

●British Committee for Standards in Haematology (BCSH): Guidelines on the investigation and management of antiphospholipid syndrome (2012, updated 2020)

Japan

●Japanese Ministry of Health, Labor and Welfare (MHLW): Treatment guide for antiphospholipid antibody syndrome, eosinophilic granulomatosis with polyangiitis, polyarteritis nodosa, and rheumatoid vasculitis (2020)

●Japanese Society of Maternal Internal Medicine: Clinical guidelines for pregnancy with antiphospholipid antibody syndrome (2016)